Professional Summary
Professional Overview
Brad Morie is a seasoned business development and licensing executive with over 20 years of experience in the pharmaceutical and biotechnology industries. As the Sr. Director at Research Corporation Technologies, Inc., he leverages his deep expertise in deal negotiations, strategic partnerships, and new product commercialization to drive growth and innovation.
Experience Summary
Current Role
In his current role as Sr. Director at Research Corporation Technologies, Inc., Brad is responsible for identifying and securing strategic partnerships, licensing agreements, and commercialization opportunities for the company's portfolio of innovative technologies. He plays a key role in evaluating potential licensing deals, negotiating contract terms, and ensuring successful technology transfer and product launches.
Career Progression
Prior to his current position, Brad held various leadership roles in business development and licensing at renowned organizations such as Ajinomoto Bio-Pharma Services, Catalent Pharma Solutions, Lonza, and Biocrates. Throughout his career, he has demonstrated a proven track record of successfully negotiating and managing complex deals, fostering collaborative partnerships, and driving the commercialization of novel products and services.
As the Director of Business Development & Licensing at Ajinomoto Bio-Pharma Services, Brad was instrumental in securing multiple strategic partnerships and licensing agreements, which significantly contributed to the company's growth and market presence. At Lonza, he played a pivotal role in expanding the company's business development and licensing activities, resulting in increased revenue and market share.
Academic Background
Brad holds a Bachelor of Science degree in Biochemistry from the University of Arizona, where he graduated with honors. He has also completed various executive education programs and industry-specific certifications, further enhancing his expertise in the pharmaceutical and biotechnology sectors.
Areas of Expertise
- Business development and licensing
- Strategic partnerships and contract negotiations
- New product commercialization and market expansion
- Technology evaluation and portfolio management
- Biotechnology and pharmaceutical industry knowledge
- Cross-functional collaboration and team leadership
Professional Impact
Throughout his career, Brad has demonstrated a strong commitment to driving innovation and growth in the pharmaceutical and biotechnology industries. He has successfully negotiated numerous licensing agreements and strategic partnerships that have enabled the development and commercialization of groundbreaking products and technologies.
As a member of the Board of Advisors at Medigen, Inc., Brad provides strategic guidance and industry expertise to support the company's product development and commercialization efforts. His contributions have been instrumental in advancing the company's pipeline and expanding its market presence.
Conclusion
With his extensive experience, industry expertise, and proven track record of success, Brad Morie is poised to continue making significant contributions to the pharmaceutical and biotechnology sectors. In his current role as Sr. Director at Research Corporation Technologies, Inc., he is committed to driving innovation, fostering strategic partnerships, and facilitating the commercialization of novel technologies that have the potential to transform the industry and improve patient outcomes.
